These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31162795)

  • 1. Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acid.
    Li R; Qin X; Liang X; Liu M; Zhang X
    J Cell Mol Med; 2019 Sep; 23(9):6017-6023. PubMed ID: 31162795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid.
    Nisha Y; Bobby Z; Wadwekar V
    Seizure; 2018 Aug; 60():57-60. PubMed ID: 29906708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis.
    Goda K; Saito K; Muta K; Kobayashi A; Saito Y; Sugai S
    J Toxicol Sci; 2018; 43(6):395-405. PubMed ID: 29877216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary metabolites of valproic acid in epileptic patients.
    Katayama H; Watanabe M; Yoshitomi H; Yoshida H; Kimoto H; Kamiya A; Hayashi T; Akimura T
    Biol Pharm Bull; 1998 Mar; 21(3):304-7. PubMed ID: 9556166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does valproate therapy in epileptic patients contribute to changing atherosclerosis risk factors? The role of lipids and free fatty acids.
    Płonka-Półtorak E; Zagrodzki P; Kryczyk-Kozioł J; Westermarck T; Kaipainen P; Kaski M; Atroshi F
    Pharmacol Rep; 2016 Dec; 68(6):1339-1344. PubMed ID: 27701058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential biomarker of fibroblast growth factor 21 in valproic acid-treated livers.
    Xu X; Guo C; Liang X; Li R; Chen J
    Biofactors; 2019 Sep; 45(5):740-749. PubMed ID: 31120577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
    Minkova GD; Getova DP
    Folia Med (Plovdiv); 2000; 42(3):16-9. PubMed ID: 11347330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
    Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M
    Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.
    Liguori C; Turner K; Izzi F; Assogna M; Canevini MP; Mercuri NB; Placidi F
    CNS Neurosci Ther; 2019 May; 25(5):632-637. PubMed ID: 30675751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
    Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
    Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
    Sidhu HS; Srinivas R; Sadhotra A
    Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy.
    Geda G; Caksen H; Içağasioğlu D
    Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid concentration and biochemical indexes in epilepsy outpatients during monotherapy or combination therapy.
    Yang X; Wang P; Pan J; Wang C; Luo J; Ma H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):782-789. PubMed ID: 32879081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese.
    Li X; Zhang J; Wu X; Yan H; Zhang Y; He RH; Tang YJ; He YJ; Tan D; Mao XY; Yin JY; Liu ZQ; Zhou HH; Liu J
    Pharmacogenomics; 2016 Dec; 17(18):2007-2014. PubMed ID: 27918244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between genetic variation in one-carbon metabolism and leukocyte DNA methylation in valproate-treated patients with epilepsy.
    Ni G; Qin J; Chen Z; Li H; Zhou J; Huang M; Zhou L
    Clin Nutr; 2018 Feb; 37(1):308-312. PubMed ID: 28161091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of metabolites of valproic acid in plasma of epileptic patients.
    Löscher W
    Epilepsia; 1981 Apr; 22(2):169-78. PubMed ID: 6781893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting serum insulin and lipid levels in men with epilepsy.
    Pylvänen V; Knip M; Pakarinen AJ; Turkka J; Kotila M; Rättyä J; Myllylä VV; Isojärvi JI
    Neurology; 2003 Feb; 60(4):571-4. PubMed ID: 12601094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ; Kwan P; Shapiro D; Dominiczak M; Brodie MJ
    Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.